Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Interest

<< Previous

Bullboard Posts

Next >>

Comment by canadapieton Aug 05, 2022 3:28am

102 Views

Post# 34873255

RE:RE:Interest

I think the new IR person is paid to keep silent.........

SPCEO1 - (8/4/2022 2:38:26 PM)

RE:Interest

I would have never imagined TH could get to this rather excruciatingly low level of being ignored. I think it might be less irritating if the stock was hated rather than ignored and we know the new IR person is looking to line up a lot of management meetings with investors

<< Previous

Bullboard Posts

Next >>

Golden Minerals closes Yoquivo gold-silver project sale